title: Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease.
abstract: We review our experience on Rifaximin in uncomplicated diverticular disease. Our data show that a 2 week treatment induces modifications in the immune system: local mucosal lymphocytes with TLR-4 were increased. In the peripheral blood CD103 cells, which increased before treatment, returned to normal values after Rifaximin.
authors.forename: F
authors.initials: F
authors.lastname: Pandolfi
authors.forename: S
authors.initials: S
authors.lastname: Frosali
authors.forename: L
authors.initials: L
authors.lastname: Petruzziello
authors.forename: E E
authors.initials: EE
authors.lastname: Newton
authors.affiliation: Institute of Internal Medicine, Catholic University of Rome, Italy. pandolfi@rm.uni.catt.it.
authors.forename: G
authors.initials: G
authors.lastname: Costamagna
mesh_terms: D004239:Diverticulitis, Colonic / Q000188:drug therapy*; D065569:Gastrointestinal Absorption / Q000187:drug effects; D000069196:Gastrointestinal Microbiome / Q000187:drug effects; D006801:Humans; D007109:Immunity / Q000187:drug effects; D018928:Immunity, Mucosal / Q000187:drug effects; D007413:Intestinal Mucosa / Q000187:drug effects; D012294:Rifamycins / Q000494:pharmacology / Q000627:therapeutic use*; D000078262:Rifaximin
chemical_list: D012294:Rifamycins; D000078262:Rifaximin